|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
11
|
|
pubmed:dateCreated |
2004-10-13
|
|
pubmed:abstractText |
Evidence exists for the pathogenic role of the enteric flora in inflammatory bowel disease. Probiotics contain living microorganisms which exert health effects on the host. We compared the efficacy in maintaining remission of the probiotic preparation Escherichia coli Nissle 1917 and established therapy with mesalazine in patients with ulcerative colitis.
|
|
pubmed:commentsCorrections |
http://linkedlifedata.com/resource/pubmed/commentcorrection/15479682-10466665,
http://linkedlifedata.com/resource/pubmed/commentcorrection/15479682-10468688,
http://linkedlifedata.com/resource/pubmed/commentcorrection/15479682-10702217,
http://linkedlifedata.com/resource/pubmed/commentcorrection/15479682-10749316,
http://linkedlifedata.com/resource/pubmed/commentcorrection/15479682-10833070,
http://linkedlifedata.com/resource/pubmed/commentcorrection/15479682-10923365,
http://linkedlifedata.com/resource/pubmed/commentcorrection/15479682-10930365,
http://linkedlifedata.com/resource/pubmed/commentcorrection/15479682-10961730,
http://linkedlifedata.com/resource/pubmed/commentcorrection/15479682-10968793,
http://linkedlifedata.com/resource/pubmed/commentcorrection/15479682-11115835,
http://linkedlifedata.com/resource/pubmed/commentcorrection/15479682-11721788,
http://linkedlifedata.com/resource/pubmed/commentcorrection/15479682-11896937,
http://linkedlifedata.com/resource/pubmed/commentcorrection/15479682-12171964,
http://linkedlifedata.com/resource/pubmed/commentcorrection/15479682-12374825,
http://linkedlifedata.com/resource/pubmed/commentcorrection/15479682-12544192,
http://linkedlifedata.com/resource/pubmed/commentcorrection/15479682-12730861,
http://linkedlifedata.com/resource/pubmed/commentcorrection/15479682-1864537,
http://linkedlifedata.com/resource/pubmed/commentcorrection/15479682-2281232,
http://linkedlifedata.com/resource/pubmed/commentcorrection/15479682-2563951,
http://linkedlifedata.com/resource/pubmed/commentcorrection/15479682-2644154,
http://linkedlifedata.com/resource/pubmed/commentcorrection/15479682-7499010,
http://linkedlifedata.com/resource/pubmed/commentcorrection/15479682-7768364,
http://linkedlifedata.com/resource/pubmed/commentcorrection/15479682-7809176,
http://linkedlifedata.com/resource/pubmed/commentcorrection/15479682-8522382,
http://linkedlifedata.com/resource/pubmed/commentcorrection/15479682-9354192,
http://linkedlifedata.com/resource/pubmed/commentcorrection/15479682-9451682,
http://linkedlifedata.com/resource/pubmed/commentcorrection/15479682-9453485,
http://linkedlifedata.com/resource/pubmed/commentcorrection/15479682-9453501,
http://linkedlifedata.com/resource/pubmed/commentcorrection/15479682-9691909
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Nov
|
|
pubmed:issn |
0017-5749
|
|
pubmed:author |
pubmed-author:BeglingerCC,
pubmed-author:DerrJ EJE,
pubmed-author:FricPP,
pubmed-author:KammM AMA,
pubmed-author:KascákMM,
pubmed-author:KruisWW,
pubmed-author:LukásMM,
pubmed-author:PokrotnieksJJ,
pubmed-author:SchulzeJJ,
pubmed-author:StolteMM,
pubmed-author:WeismuellerJJ,
pubmed-author:WolfeDD
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
53
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1617-23
|
|
pubmed:dateRevised |
2009-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:15479682-Adult,
pubmed-meshheading:15479682-Aged,
pubmed-meshheading:15479682-Aged, 80 and over,
pubmed-meshheading:15479682-Anti-Inflammatory Agents, Non-Steroidal,
pubmed-meshheading:15479682-Colitis, Ulcerative,
pubmed-meshheading:15479682-Double-Blind Method,
pubmed-meshheading:15479682-Escherichia coli,
pubmed-meshheading:15479682-Female,
pubmed-meshheading:15479682-Humans,
pubmed-meshheading:15479682-Male,
pubmed-meshheading:15479682-Mesalamine,
pubmed-meshheading:15479682-Middle Aged,
pubmed-meshheading:15479682-Probiotics,
pubmed-meshheading:15479682-Recurrence,
pubmed-meshheading:15479682-Remission Induction
|
|
pubmed:year |
2004
|
|
pubmed:articleTitle |
Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine.
|
|
pubmed:affiliation |
Evangelisches Krankenhaus Kalk, University of Cologne, Germany. ansorg@evkk.de.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Multicenter Study
|
